Circulating tumor cell eradication as an intermediate efficacy end point for metastatic castration-resistant prostate cancer: Is there enough evidence?

Research output: Contribution to journalEditorialpeer-review

Original languageEnglish (US)
Pages (from-to)525-527
Number of pages3
JournalJournal of Clinical Oncology
Volume36
Issue number6
DOIs
StatePublished - Feb 20 2018

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this